Assessing Cardiovascular Risk through Insulin Resistance and Inflammation

4972 Big Island Drive,Jacksonville FL 32246

21 July, 2022

Description

Many chronic conditions, including Cardiovascular Disease, Type II Diabetes, Chronic Kidney Disease, Non-Alcoholic Fatty Liver Disease are rooted in insulin resistance and are clinically silent in their early stages. Identification of early metabolic dysfunction provides a unique opportunity for stage-targeted intervention and management to prevent disease progression. • Review population health trends in cardiovascular mortality and metabolic dysfunction • Discuss how metabolic dysfunction contributes to cardiovascular disease and other chronic conditions • Learn about the clinical solution for early identification of metabolic risk ***As a courtesy, Vasolabs will be offering FREE Mini CIMT's to those providers who are in attendance**